Cargando…
Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
Autores principales: | Jimenez, J, Iribarren, J, Brouard, M, Barrios, Y, Raya, J, Lorente, L, Perez, R, Garcia, C, Martinez, J, Martinez, R, Mora, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095308/ http://dx.doi.org/10.1186/cc5415 |
Ejemplares similares
-
Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
por: Iribarren, J, et al.
Publicado: (2007) -
Tranexamic acid effects on postoperative bleeding in cardiopulmonary bypass surgery according to the plasminogen activator inhibitor-1 polymorphism
por: Brouard, M, et al.
Publicado: (2008) -
Vasoplegic syndrome in cardiac surgery: role of synergism between polymorphism of tumor necrosis factor beta and plasminogen activator inhibitor type 1
por: Iribarren, JL, et al.
Publicado: (2015) -
Complement activation and excessive bleeding in cardiopulmonary bypass surgery
por: Iribarren, J, et al.
Publicado: (2007) -
Impact of body mass index on postoperative bleeding in cardiopulmonary bypass
por: Brouard, M, et al.
Publicado: (2007)